Royalty Pharma plc

Royalty Pharma plc financial statements

Royalty Pharma plc's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 2.38B10-K
Net incomeUSD 770.95M10-K
Cash and equivalentsUSD 618.7M10-Q
Total debtUSD 8.95B10-Q

Royalty Pharma plc financials on 6ix · Royalty Pharma plc on 6ix